Necessity and precautions for long-term use of bedaquiline
In anti-tuberculosis treatment, bedaquiline (Bedaquiline) is a specific drug for multidrug-resistant tuberculosis (MDR-TB). Its use period is usually long, but the specific medication time needs to be determined according to the patient's specific condition and the treatment plan formulated by the doctor. As MDR-TB is resistant to traditional first-line anti-tuberculosis drugs such as isoniazid and rifampicin, the treatment process is more complicated and the time required is correspondingly longer.
The standard treatment cycle of bedaquiline is set to 24 weeks, which is approximately 6 months. During treatment, this drug needs to be used in combination with other anti-tuberculosis drugs to form a powerful antibacterial synergy. The treatment plan is divided into two stages: within the first two weeks, patients need to take 400 mg once a day, three times a week; From the beginning of the >week to the end of the 24th week, the dose is adjusted to be taken only once a week, 200mg each time. This long-term and phased drug strategy aims to ensure that the drug can continuously and effectively inhibit the growth and proliferation of Mycobacterium tuberculosis, thereby reducing the risk of the bacteria developing further drug resistance.

Given the slow growth rate of M. tuberculosis and the high resistance of MDR-TB to conventional treatments, patients must strictly adhere to long-term drug regimens. Any interruption of treatment or failure to complete it as planned may result in the inability of the bacteria to be completely eliminated, leading to treatment failure and even aggravating the resistance of the bacteria.
However, long-term use of bedaquiline is also associated with certain risks, especially adverse effects on the heart and liver. This drug may prolong theQTinterval, thereby increasing the risk of cardiac arrhythmias. Therefore, during treatment, patients need to undergo regular electrocardiogram monitoring to detect and deal with potential heart problems in a timely manner. At the same time, bedaquiline may also affect liver function, so regular blood tests are also essential to ensure that the negative effects of the drug on the body are controlled in time.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)